img

Global Adult Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Adult Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2034

Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Market Analysis and InsightsGlobal Adult Attention Deficit and Hyperactivity Disorder Market
Global Adult Attention Deficit and Hyperactivity Disorder market is expected to reach to US$ 11850 million in 2024, with a positive growth of %, compared with US$ 11080 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Adult Attention Deficit and Hyperactivity Disorder industry is evaluated to reach US$ 17780 million in 2029. The CAGR will be 7.0% during 2024 to 2029.
The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.
Report Covers
This report presents an overview of global Adult Attention Deficit and Hyperactivity Disorder market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Adult Attention Deficit and Hyperactivity Disorder market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Segment by Type
Stimulant
Non-stimulant

Segment by Application


Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Adult Attention Deficit and Hyperactivity Disorder introduction, etc. Adult Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Adult Attention Deficit and Hyperactivity Disorder
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Perspective (2018-2029)
2.2 Global Adult Attention Deficit and Hyperactivity Disorder Growth Trends by Region
2.2.1 Adult Attention Deficit and Hyperactivity Disorder Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Adult Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2018-2024)
2.2.3 Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2024-2029)
2.3 Adult Attention Deficit and Hyperactivity Disorder Market Dynamics
2.3.1 Adult Attention Deficit and Hyperactivity Disorder Industry Trends
2.3.2 Adult Attention Deficit and Hyperactivity Disorder Market Drivers
2.3.3 Adult Attention Deficit and Hyperactivity Disorder Market Challenges
2.3.4 Adult Attention Deficit and Hyperactivity Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Adult Attention Deficit and Hyperactivity Disorder by Players
3.1.1 Global Adult Attention Deficit and Hyperactivity Disorder Revenue by Players (2018-2024)
3.1.2 Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2018-2024)
3.2 Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Adult Attention Deficit and Hyperactivity Disorder Market Concentration Ratio
3.4.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adult Attention Deficit and Hyperactivity Disorder Revenue in 2022
3.5 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder Head office and Area Served
3.6 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Product and Application
3.7 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adult Attention Deficit and Hyperactivity Disorder Breakdown Data by Type
4.1 Global Adult Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2018-2024)
4.2 Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2024-2029)
5 Adult Attention Deficit and Hyperactivity Disorder Breakdown Data by Application
5.1 Global Adult Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2018-2024)
5.2 Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Adult Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
6.2 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type
6.2.1 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024)
6.2.2 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029)
6.2.3 North America Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
6.3 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application
6.3.1 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024)
6.3.2 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029)
6.3.3 North America Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
6.4 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country
6.4.1 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2024)
6.4.3 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
7.2 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Type
7.2.1 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024)
7.2.2 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029)
7.2.3 Europe Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
7.3 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Application
7.3.1 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024)
7.3.2 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029)
7.3.3 Europe Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
7.4 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country
7.4.1 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2024)
7.4.3 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Adult Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
8.2 China Adult Attention Deficit and Hyperactivity Disorder Market Size by Type
8.2.1 China Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024)
8.2.2 China Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029)
8.2.3 China Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
8.3 China Adult Attention Deficit and Hyperactivity Disorder Market Size by Application
8.3.1 China Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024)
8.3.2 China Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029)
8.3.3 China Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
9.2 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Type
9.2.1 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024)
9.2.2 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029)
9.2.3 Asia Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
9.3 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Application
9.3.1 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024)
9.3.2 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029)
9.3.3 Asia Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
9.4 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Region
9.4.1 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2024)
9.4.3 Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type
10.2.1 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application
10.3.1 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country
10.4.1 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Adult Attention Deficit and Hyperactivity Disorder Introduction
11.1.4 Takeda Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.1.5 Takeda Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Introduction
11.2.4 Johnson & Johnson Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Adult Attention Deficit and Hyperactivity Disorder Introduction
11.3.4 Novartis Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Introduction
11.4.4 Eli Lilly Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.4.5 Eli Lilly Recent Developments
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Introduction
11.5.4 Tris Pharma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.5.5 Tris Pharma Recent Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Introduction
11.6.4 Neos Therapeutics Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.6.5 Neos Therapeutics Recent Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Introduction
11.7.4 Mallinckrodt Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.7.5 Mallinckrodt Recent Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.8.5 Amneal Pharmaceuticals Recent Developments
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Introduction
11.9.4 Noven Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.9.5 Noven Pharmaceuticals Recent Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Introduction
11.10.4 Purdue Parma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
11.10.5 Purdue Parma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Stimulant
Table 3. Key Players of Non-stimulant
Table 4. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Region (2018-2024)
Table 8. Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Region (2024-2029)
Table 10. Adult Attention Deficit and Hyperactivity Disorder Market Trends
Table 11. Adult Attention Deficit and Hyperactivity Disorder Market Drivers
Table 12. Adult Attention Deficit and Hyperactivity Disorder Market Challenges
Table 13. Adult Attention Deficit and Hyperactivity Disorder Market Restraints
Table 14. Global Adult Attention Deficit and Hyperactivity Disorder Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Share by Players (2018-2024)
Table 16. Global Top Adult Attention Deficit and Hyperactivity Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Attention Deficit and Hyperactivity Disorder as of 2022)
Table 17. Global Adult Attention Deficit and Hyperactivity Disorder Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Adult Attention Deficit and Hyperactivity Disorder Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Headquarters and Area Served
Table 20. Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Product and Application
Table 21. Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2018-2024)
Table 25. Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2024-2029)
Table 27. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Share by Application (2018-2024)
Table 29. Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Share by Application (2024-2029)
Table 31. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Adult Attention Deficit and Hyperactivity Disorder Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Adult Attention Deficit and Hyperactivity Disorder Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Adult Attention Deficit and Hyperactivity Disorder Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 63. Takeda Company Details
Table 64. Takeda Business Overview
Table 65. Takeda Adult Attention Deficit and Hyperactivity Disorder Product
Table 66. Takeda Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 67. Takeda Recent Developments
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Product
Table 71. Johnson & Johnson Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 72. Johnson & Johnson Recent Developments
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Adult Attention Deficit and Hyperactivity Disorder Product
Table 76. Novartis Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 77. Novartis Recent Developments
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Product
Table 81. Eli Lilly Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 82. Eli Lilly Recent Developments
Table 83. Tris Pharma Company Details
Table 84. Tris Pharma Business Overview
Table 85. Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Product
Table 86. Tris Pharma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 87. Tris Pharma Recent Developments
Table 88. Neos Therapeutics Company Details
Table 89. Neos Therapeutics Business Overview
Table 90. Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Product
Table 91. Neos Therapeutics Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 92. Neos Therapeutics Recent Developments
Table 93. Mallinckrodt Company Details
Table 94. Mallinckrodt Business Overview
Table 95. Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Product
Table 96. Mallinckrodt Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 97. Mallinckrodt Recent Developments
Table 98. Amneal Pharmaceuticals Company Details
Table 99. Amneal Pharmaceuticals Business Overview
Table 100. Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Product
Table 101. Amneal Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 102. Amneal Pharmaceuticals Recent Developments
Table 103. Noven Pharmaceuticals Company Details
Table 104. Noven Pharmaceuticals Business Overview
Table 105. Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Product
Table 106. Noven Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 107. Noven Pharmaceuticals Recent Developments
Table 108. Purdue Parma Company Details
Table 109. Purdue Parma Business Overview
Table 110. Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Product
Table 111. Purdue Parma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024) & (US$ Million)
Table 112. Purdue Parma Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Type: 2022 VS 2029
Figure 3. Stimulant Features
Figure 4. Non-stimulant Features
Figure 5. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Adult Attention Deficit and Hyperactivity Disorder Report Years Considered
Figure 11. Global Adult Attention Deficit and Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Adult Attention Deficit and Hyperactivity Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Region: 2022 VS 2029
Figure 14. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Players in 2022
Figure 15. Global Top Adult Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Attention Deficit and Hyperactivity Disorder as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Adult Attention Deficit and Hyperactivity Disorder Revenue in 2022
Figure 17. North America Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
Figure 19. North America Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
Figure 20. North America Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029)
Figure 21. United States Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
Figure 25. Europe Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
Figure 26. Europe Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029)
Figure 27. Germany Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Adult Attention Deficit and Hyperactivity Disorder Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
Figure 35. China Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
Figure 36. Asia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
Figure 38. Asia Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
Figure 39. Asia Adult Attention Deficit and Hyperactivity Disorder Market Share by Region (2018-2029)
Figure 40. Japan Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2018-2029)
Figure 50. Brazil Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Takeda Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 57. Johnson & Johnson Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 58. Novartis Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 59. Eli Lilly Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 60. Tris Pharma Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 61. Neos Therapeutics Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 62. Mallinckrodt Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 63. Amneal Pharmaceuticals Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 64. Noven Pharmaceuticals Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 65. Purdue Parma Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed